Ventricular Arrhythmias With Congenital Heart Disease Causing Sudden Death

Abstract

A remarkable number of deaths in foetal cardiac disorders have been reduced as a result of significant gains in survival. Arrhythmias are most common issue that patients encounter. Expert societies have issued evidence-based recommendations for addressing the distinctive disputes and problems of dealing arrhythmias in patients with congenital cardiac ailment, as well as critical judgments for sudden death prevention. Continued progresses in hazard evaluation and technology are capable to develop the safety and efficacy of this rapidly growing patient population. This ventricular remodelling, like other forms of heart disease, unexpected death, ventricular tachycardia (VT) and ventricular fibrillation (VF). A large ventricular patch induces prolonged monomorphic reentrant VT, which can cause haemodynamic failure and abrupt cardiac death. Severe VT and VF treatment can be performed according to standard procedures. Chronic management includes heart failure therapies and healing therapy for the underlying congenital heart defect, but particular arrhythmia managing is best delivered by an experienced electrophysiologist who can accurately identify arrhythmia and its pathway, offer analytical stratification, govern the substrate, and control specialty electrical treatments like antitachycardia pacing and implantable cardiac defibrillation via an impedance monitor. Finally, electrophysiological analysis can assist the surgeon in determining if arrhythmia-neutralizing incisions should be included in the reparative surgery.